Empagliflozin Is Associated with Increased Plasma Lipid Metabolites in Type 1 Diabetes

Empagliflozin Benzhydryl compounds
DOI: 10.1681/asn.20203110s1345b Publication Date: 2024-05-17T19:54:44Z